SavedAdd your journal

Journals / Ege Klinikleri Tıp Dergisi / 2020 / Cilt: 58 - Sayı: 1

CoronavirüsesCovid-19 IllnessFromThePerspectiveof InfectiousDisease

Enfeksiyon Hastalıkları Açısından Koronavirüs: Covid-19 Hastalığı

Canan GÜRSOY
Turhan TOGAN
Emrah DOĞAN
Pages
19–23
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Coronaviruses(CoV)haveanenvelopedsingle-strandedRNAgenomeandarehighlypathogenic.Transmissionoccursthroughdropletinfection(respiratorysecretions)andclosecontactfrompersontoperson.Theincubationperiodis2-14daysandtheaverageis5-6days.Themostcommonfindingsofthedisease,whichisspreadallovertheworldandacceptedasPandemic;arehighfever,drycough,weakness,fatigue,shortnessofbreath,sorethroat,headacheandmusclejointpain.Inthelightofcurrentknowledgethemortalityrateisabout3.4%.Thereisnospecificantiviraldrugfortreatmentyet.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Coronaviruses(CoV)haveanenvelopedsingle-strandedRNAgenomeandarehighlypathogenic.Transmissionoccursthroughdropletinfection(respiratorysecretions)andclosecontactfrompersontoperson.Theincubationperiodis2-14daysandtheaverageis5-6days.Themostcommonfindingsofthedisease,whichisspreadallovertheworldandacceptedasPandemic;arehighfever,drycough,weakness,fatigue,shortnessofbreath,sorethroat,headacheandmusclejointpain.Inthelightofcurrentknowledgethemortalityrateisabout3.4%.Thereisnospecificantiviraldrugfortreatmentyet.
📊
Key Findings & Data:Coronaviruses(CoV)haveanenvelopedsingle-strandedRNAgenomeandarehighlypathogenic.Transmissionoccursthroughdropletinfection(respiratorysecretions)andclosecontactfrompersontoperson.Theincubationperiodis2-14daysandtheaverageis5-6days.Themostcommonfindingsofthedisease,whichisspreadallovertheworldandacceptedasPandemic;arehighfever,drycough,weakness,fatigue,shortnessofbreath,sorethroat,headacheandmusclejointpain.Inthelightofcurrentknowledgethemortalityrateisabout3.4%.Thereisnospecificantiviraldrugfortreatmentyet.
💡
Conclusion & Impact:Coronaviruses(CoV)haveanenvelopedsingle-strandedRNAgenomeandarehighlypathogenic.Transmissionoccursthroughdropletinfection(respiratorysecretions)andclosecontactfrompersontoperson.Theincubationperiodis2-14daysandtheaverageis5-6days.Themostcommonfindingsofthedisease,whichisspreadallovertheworldandacceptedasPandemic;arehighfever,drycough,weakness,fatigue,shortnessofbreath,sorethroat,headacheandmusclejointpain.Inthelightofcurrentknowledgethemortalityrateisabout3.4%.Thereisnospecificantiviraldrugfortreatmentyet.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Coronaviruses(CoV)haveanenvelopedsingle-strandedRNAgenomeandarehighlypathogenic.Transmissionoccursthroughdropletinfection(respiratorysecretions)andclosecontactfrompersontoperson.Theincubationperiodis2-14daysandtheaverageis5-6days.Themostcommonfindingsofthedisease,whichisspreadallovertheworldandacceptedasPandemic;arehighfever,drycough,weakness,fatigue,shortnessofbreath,sorethroat,headacheandmusclejointpain.Inthelightofcurrentknowledgethemortalityrateisabout3.4%.Thereisnospecificantiviraldrugfortreatmentyet.

Özet

Koronavirüsler(CoV),zarflıteksarmallıbirRNAgenomunasahipolupyüksekderecedepatojeniktir.Bulaş;damlacıkenfeksiyonu(solunumsalgıları)vekişidenkişiyeyakıntemasyoluylagerçekleşir.Kuluçkasüresi2-14günoluportalama5-6gündür.TümdünyayayayılanvePandemikabuledilenhastalığınensıkgörülenbulguları;yüksekateş,kuruöksürük,halsizlik,yorgunluk,nefesdarlığı,boğazağrısı,başağrısı,kaseklemağrılarıdır.Bugünkibilgilerışığındaölümoranıyaklaşık%3.4tür.Tedaviiçinspesifikbirantiviralilaçhenüzyoktur.

🔖

Cite This Article

GÜRSOY, C., TOGAN, T., DOĞAN, E. (2022). CoronavirüsesCovid-19 IllnessFromThePerspectiveof InfectiousDisease. Ege Klinikleri Tıp Dergisi, Cilt: 58 - Sayı: 1, 19–23. https://ajindex.com/articles/495668

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (8)

  1. Yang H, Bartlam M, Rao Z. Drug design targeting the main protease, the Achilles' heel of coronaviruses. Curr Pharm Des. 2006
  2. 4573– 90. [PubMed] [Google Scholar] 2. Hilgenfeld R. From SARS to MERS: Crystallographic studies on coronaviral proteases enable antiviral drug design. FEBS J. 2014
  3. 4085– 96. [PubMed] [Google Scholar] 3. Paules CI, Marston HD, Fauci AS. Coronavirus infections-More than just the common cold. JAMA. 2020
  4. [PubMed] [Google Scholar] 4. McBride R, van Zyl M, Fielding BC. The coronavirus nucleocapsid is a multifunctional protein. Viruses. 2014
  5. 2991–3018. [PMC free article] [PubMed] [Google Scholar] 5. Li F. Structure, function, and evolution of coronavirus spike proteins. Annu Rev Virol.2016
  6. 237–61. [PMC free article] [PubMed] [Google Scholar] 6. Prajapat M, et al. Drug targets for corona virus: A systematic review. Indian journal of pharmacology, 2020, 52.1: 56. 7. Neeltje van Doremalen, Trenton Bushmaker, Dylan H. Morris, Myndi G. Holbrook, Amandine. Aerosol and surface stability of HCoV-19 (SARS-CoV-6 2) compared to SARS-CoV-1. doi: https://doi.org/10.1101/2020.03.09.20033217. 8. AlexWH Chin, Julie TS Chu, Mahen RS Perera, Kenrie PY Hui et al.Stability of SARS-CoV-2 in different environmental conditions.April 02, 2020 DOİ:10.1016/S2666-5247(20)30003-3 9. Buruk K, Özlü T.New Coronavirus:SARS-CoV-2.MucosaMarch2020 V3 N1,1- 4. doi:10.33204/mucosa.706906 10. Clinical Characteristics of Covid-19 in China. The New England Journal of Medicine Downloaded from nejm.org on April 7, 2020. 11. Lin SY, Liu CL, Chang YM, Zhao J, Perlman S, Hou MH. Structural basis for the identification of the N-terminal domain of coronavirus nucleocapsid protein as an antiviral target. J Med Chem. 2014
  7. 2247–57. [PMC free article] [PubMed] [Google Scholar] 12. Shimamoto Y, Hattori Y, Kobayashi K, Teruya K, Sanjoh A, Nakagawa A, et al. Fused-ring structure of decahydroisoquinolin as a novel scaffold for SARS 3CLprotease inhibitors. Bioorg Med Chem. 2015
  8. 876–90. [PMC free article] [PubMed][Google Scholar] 13. Three Drugs Fairly Effective on Novel Coronavirus at Cellular Level- Xinhua. [Last accessed on 2020 Feb 03]. Available from: http://www.xinhuanet.com/english/2020-01/30/c_138742163.htm. 14. Chinese Clinical Trial Register (ChiCTR)-The World Health Organization International Clinical Trials Registered Organization Registered Platform. [Last accessed on 2020 Feb 24]. Available from: http://www.chictr.org.cn/abouten.aspx. 15. Neeltje van